Rudolph, Anja 1982-
Anja Rudolph researcher
VIAF ID: 295426799 (Personal)
Permalink: http://viaf.org/viaf/295426799
Preferred Forms
- 100 0 _ ‡a Anja Rudolph ‡c researcher
- 100 1 _ ‡a Rudolph, Anja ‡d 1982-
- 100 1 _ ‡a Rudolph, Anja ‡d 1982-
4xx's: Alternate Name Forms (1)
5xx's: Related Names (4)
- 510 2 _ ‡a Deutsches Krebsforschungszentrum ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Fulda ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 551 _ _ ‡a Heidelberg ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a IQVIA ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk | |
Dietary inflammation potential and postmenopausal breast cancer risk in a German case-control study | |
DNA mismatch repair gene MSH6 implicated in determining age at natural menopause | |
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk | |
Estimating the heritability of colorectal cancer | |
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. | |
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study | |
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation | |
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. | |
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). | |
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus | |
Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci | |
Genetic predisposition to in situ and invasive lobular carcinoma of the breast | |
Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin | |
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study | |
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade | |
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium | |
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent | |
A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. | |
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. | |
GWAS-identified common variants for obesity are not associated with the risk of developing colorectal cancer. | |
High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium | |
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk | |
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus | |
Identification of six new susceptibility loci for invasive epithelial ovarian cancer | |
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer | |
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression | |
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium | |
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome | |
Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair | |
Large-scale genotyping identifies 41 new loci associated with breast cancer risk | |
Mediation of sex steroid effects on colorectal cancer risk and survival influence of genetic variation and estrogen receptor beta expression | |
Mendelian randomization study of height and risk of colorectal cancer | |
Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes | |
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | |
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk | |
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. | |
No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk | |
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing | |
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS | |
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche | |
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium | |
Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies | |
Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer | |
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression | |
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women | |
Prediction of breast cancer risk based on profiling with common genetic variants | |
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups | |
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. | |
RAD51B in Familial Breast Cancer | |
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | |
Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort | |
Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study | |
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. | |
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 | |
Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases | |
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer | |
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer | |
Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. | |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer | |
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies | |
The UGT1A6_19_GG genotype is a breast cancer risk factor | |
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer |